It looks like you are visiting our site on a browser that is really old. Unfortunately, this means you can’t get the full experience. It’d be awesome if you could upgrade to a modern browser, especially Chrome and Firefox as that is the best out there right now.
5UT Health Science Center: 210 562 4035
UTSA: 210 458 6767
The San Antonio Life Sciences Institute, a joint venture between The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio (HSC), has selected the winners of the Postdoc Initiative Pilot Program. The winners, Emily Boice from UTSA and Lei Huang from HSC, will receive $25,000 for their project titled, “Novel engineered ferritins for tracking and protecting neural stem cells in post-ischemic environment.”
The research of Boice and Huang focuses on a treatment for stroke through stem cell therapy. Stem cell therapy is a promising treatment for stroke, but is not without its challenges. After a stroke, the brain has a deficient supply of blood and areas surrounding it are filled with toxic iron. This toxicity is damaging to engrafted stem cells and prevents stem cell induced healing. Boice and Huang are working on an innovative way to protect stem cells in the post-stroke, hostile environment and allow for them to be tracked by MRI machines.
Since stroke is the fourth leading cause of death and the leading cause of long-term disability worldwide, their research into this field could not only change the landscape of the disease in Texas, but also the world.
The SALSI Postdoc Initiative program sought to bring together innovative postdoctoral research fellows from UTSA and HSC to collaborate on the development of novel solutions that will ultimately advance research directions in targeted disease areas which impact the south Texas region. This initiative aims to benefit both postdoctoral fellows and their faculty mentors by introducing new technologies, expanding the research focus, and yielding data for innovative research proposals.